Results 21 to 30 of about 1,437,512 (207)

Artifactual hypoglycemia caused by Raynaud’s phenomenon: A case report with literature review [PDF]

Frontiers in Endocrinology
Finger-stick glucose monitoring is commonly used in the clinical management of diabetes as a tool to obtain a reliable estimate of venous glucose levels.
Hidenori Nishioka, Takeshi Yamamotoya, Yuki Itoda, Chikako Ichikawa, Mai Nishiyama, Masahiro Takubo, Akiko Nagasawa, Minami Kosuda, Fujiko Egashira, Midori Fujishiro, Kentaro Watanabe, Hisamitsu Ishihara   +11 more
doaj   +2 more sources

Local cold injury affecting the hand and incident Raynaud’s phenomenon – a case report [PDF]

International Journal of Circumpolar Health
There is an association between local cold injuries and Raynaud’s phenomenon (RP) in the scientific literature, but the time relation and anatomical correlation have not been established.
Albin Stjernbrandt
doaj   +2 more sources

Raynaud’s phenomenon on initiation of Lithium therapy: a case report [PDF]

BMC Psychiatry
Lithium Carbonate is an effective treatment for affective disorders, but has a range of side effects. This case report highlights a rare side effect of Raynaud’s phenomenon following initiation of Lithium therapy in a patient with recurrent depressive ...
Cailín Boland, Emma Adams, Man Ching Wong, Cian Denihan   +3 more
doaj   +2 more sources

Application of the infrared thermography method in diagnosis of Raynaud`s phenomenon

Medičnì Perspektivi, 2023
The development of modern diagnostic medicine, the important task of which is the use of non-invasive methods for detecting a disease without impact of radiation exposure, has led to the spread of the method of infrared thermography, which allows to ...
D.I. Zabolotnyi, T.V. Loboda, V.I. Dunaievskyi, V.Y. Kotovskyi , V.I. Timofeiev , S.S. Nazarchuk   +5 more
doaj   +1 more source

Calcitonin gene-related peptide-targeting drugs and Raynaud’s phenomenon: a real-world potential safety signal from the WHO pharmacovigilance database

The Journal of Headache and Pain, 2022
Background Migraine is responsible for significant disability and societal burden. Recently, drugs targeting the calcitonin gene-related peptide (CGRP) pathway raised new hopes. CGRP, a potent vasodilator, plays a key role in the pathogenesis of migraine
Alexandre O. Gérard, Diane Merino, Elise K. Van Obberghen, Fanny Rocher, Alexandre Destere, Michel Lantéri-Minet, Milou-Daniel Drici   +6 more
doaj   +1 more source

Incidence, remission, and persistence of Raynaud’s phenomenon in the general population of northern Sweden: a prospective study

BMC Rheumatology, 2022
Background Raynaud’s phenomenon is common condition, but little is known about the natural course. The primary aim of this study was to determine the incidence, remission, and persistence proportions of Raynaud’s phenomenon in the general population of ...
Albin Stjernbrandt, Hans Pettersson, Ronnie Lundström, Ingrid Liljelind, Tohr Nilsson, Jens Wahlström   +5 more
doaj   +1 more source

Aptamer proteomics of serum exosomes from patients with Primary Raynaud's and patients with Raynaud's at risk of evolving into Systemic Sclerosis.

PLoS ONE, 2022
BackgroundA major unmet need for Systemic Sclerosis (SSc) clinical management is the lack of biomarkers for the early diagnosis of patients with Raynaud's Phenomenon at high risk of evolving into SSc.ObjectiveTo identify proteins contained within serum ...
Sonsoles Piera-Velazquez, Simon T Dillon, Xuesong Gu, Towia A Libermann, Sergio A Jimenez   +4 more
doaj   +1 more source

Impact of global warming on Raynaud’s phenomenon: a modelling study [version 1; peer review: 2 approved]

F1000Research, 2020
Background: Raynaud’s phenomenon is induced by excessive vasoconstriction of the peripheral microcirculation in response to environmental factors, essentially cold, but also stress or emotions. The objective of the present study is to evaluate the impact
Charles Khouri, Matthieu Roustit, Jean-Luc Cracowski   +2 more
doaj   +1 more source

Vasodilators for primary Raynaud's phenomenon

, 2021
BACKGROUND: Numerous agents have been suggested for the symptomatic treatment of primary Raynaud's phenomenon. Apart from calcium channel blockers, which are considered to be the drugs of choice, evidence of the effects of alternative pharmacological ...
Abdeen, Mohamed Hashim, Kaganov, E, Sharma, M, Ng, JHK, Abdeen, MH, Sharma, Meghna, Kim, Hyunjun Jonathan, Su, Kevin YC, Kim, HJ, Hughes, Ian, Su, KYC, Kaganov, Elizabeth, Ng, Jennifer Hwee Kwoon, Hughes, I   +13 more
core   +1 more source

Raynaud’s Phenomenon

New England Journal of Medicine, 1996
Raynaud's phenomenon is a common clinical problem occurring in 3% to 5% of the general population. The first symptom of scleroderma is often Raynaud's phenomenon, which is associated with a diffuse small vessel vasculopathy and ischemia and reperfusion injury to skin and other organs targeted in this disease.
F M, Wigley, N A, Flavahan
openaire   +3 more sources